Different stem cell types defined by exclusive combinations of genes working together

In the new issue of Cell Stem Cell, scientists report that the same transcription factor, which is crucial for the survival of different stem cell types, can behave differently.

This study clearly showed for the first time that different types of stem cells are defined by exclusive combinations of genes working together, and this is under the influence of a single key stem cell factor (called Sall4).

The finding is timely since other researchers have recently revealed that specific genetic recipes can be used to turn non-stem cells into different stem cells that can be useful clinically.

This finding reveals important insights about how scientists may be able to manipulate and engineer different stem cells for the treatment of human degenerative disorders.

Understanding the behaviour of transcription factors, a class of gene regulators, helps pave the way for important advancements in stem cell technology and clinical research.

Stem cells are important for the cell-based therapy of many degenerative tissue disorders. Each type of body tissue has its own unique type of stem cells whose behaviour is controlled by different sets of genes.

Given the enormous complexity of each stem cell type and the underlying genetic bases for their unique purpose, it has been a major challenge for scientists to unravel the similarities and differences between the different stem cells.

The latest research, led by Bing Lim, Senior Group Leader at the Genome Institute of Singapore (GIS), focused on identifying and understanding the functions of powerful genetic molecules, also known as "stem cell factors".

Dr. Bing Lim said, "This new discovery has provided us with important new leads and ideas on how to grow and expand various stem cells for clinical research and treatment needs."

Dr. Daniel Tenen, Professor of Medicine at Harvard Medical School, and Director for Cancer Research Centre of Excellence at the National University of Singapore, said, "These studies are of great significance, as they provide important clues as to how a single transcription factor might regulate different targets in different stem cells."

Interestingly, this stem cell factor also appeared to be associated with certain diseases, particularly leukemia.

Dr. Li Chai, Instructor at the Department of Pathology at the Harvard Medical School, added that, "as Sall4 plays an important role in both normal hematopoietic stem cell function and in leukemia stem cells, these findings may have clinical relevance; they may lead to understanding differences between normal and cancer stem cells."

Source: Agency for Science, Technology and Research (A*STAR), Singapore

Related stories:

Mapping brain cancer to find best treatment
There's never a good time to have brain cancer. Still, Karl DuBose tries to look on the bright side. "It's weird to say, but today - and here in Seattle - might be the best time and place to get this disease," said the 45-year-old Everett, Wash., man, who was slammed with the diagnosis last summer.
Stem cell obstacles
"There are still a number of major hurdles in the path of stem cell research today that are preventing the routine application of the technology in regenerative medicine." So say UK scientists writing in a forthcoming issue of the International Journal of Biotechnology.
Where does the gene activity of youth go? New findings may hold the key
New evidence may explain why it is that we lose not only our youthful looks, but also our youthful pattern of gene activity with age. A report in the November 26th issue of the journal Cell, a Cell Press publication, reveals that a protein perhaps best known for its role in the life-extending benefits of a low-calorie diet also maintains the stability of the mammalian genome—the complete set of genetic instructions "written" in DNA.
Kidney function discovery sheds light on genetic complexity of disease
To find a cure for cancer, haemophilia and other diseases, researchers need to be looking for complex, interacting genetic factors, according to the authors of a new study.
Scientists achieve repair of injured heart muscle in lab tests of stem cells
Researchers at Children's Hospital of Pittsburgh of UPMC have been able to effectively repair damaged heart muscle in an animal model using a novel population of stem cells they discovered that is derived from human skeletal muscle tissue.
'Embryo adoption' service seeks to give infertile couples a chance to have a family
The day the frozen embryo arrived via FedEx was the day Maria Lancaster began experiencing firsthand what she had always believed: that human life begins at conception.
Researchers investigate how plants adapt to climate
(PhysOrg.com) -- How many mouths does a plant need in order to survive? The answer changes depending on climate, and some of the decisions are made long before a new leaf sprouts.
Physicists Receive Patent for Improved Cancer Therapy Device
Four physicists at the U.S. Department of Energy's Brookhaven National Laboratory have been awarded U.S. Patent No. 7,432,516 B2 for the design of a “medical synchrotron” capable of delivering precision doses of proton radiation to cancerous tumors with minimal damage to surrounding healthy tissue. The new device would be more precise and less costly than existing proton-therapy systems, potentially increasing the availability and benefits of this treatment for cancer patients worldwide. The Brookhaven scientists are now seeking industrial partners to license and commercialize the technology.

News discussion:

General Science news